(Note: We appreciate your support for businesses like the one featured below, which helps sustain Gateway Pundit. Your collaboration with them through the links below is invaluable!)
The Unraveling of Medical Integrity: A Post-Pandemic Awakening
While the notion of greed infiltrating medicine is hardly groundbreaking, the COVID-19 pandemic has catalyzed a growing awareness among Americans: the medical establishment often prioritizes profits over patient care.
It’s no shocker, then, that pharmaceutical giants and the broader healthcare industry show little enthusiasm for low-cost treatment options, especially for lucrative conditions like cancer.
However, a beacon of hope emerges as a cadre of dedicated medical professionals strives to restore trust in our healthcare system by advocating for affordable and effective treatment options for all.
One such advocate, Dr. William Makis, has gained notoriety for his vocal criticisms of the pandemic response and his endorsement of Ivermectin and mebendazole as potential treatments for various cancers.
Dr. Makis has compiled a list of 20 studies demonstrating Ivermectin’s potential efficacy against cancer:
Recent Studies on IVERMECTIN’s Application in Specific Cancer Types:
-
BLADDER CANCER – (2024 Fan et al) – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage
-
LUNG CANCER – (2024 Man-Yuan Li et al) – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
-
GLIOMA – (2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma
-
MULTIPLE MYELOMA – (2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
-
OVARIAN CANCER – (2023 Jawad et al) – Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells
-
PROSTATE CANCER – (2022 Lu et al) – Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
-
COLON CANCER – (2022, Alghamdi et al) – Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats
-
PANCREATIC CANCER – (2022 Lee et al) – Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
-
MELANOMA – (2022 Zhang et al) – Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis
-
CERVICAL CANCER – (2022, Qabbus et al) – Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media
-
HEPATOCELLULAR CARCINOMA – (2022 Lu et al) – Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
-
OSTEOSARCOMA – (2022 Hu et al) – Repurposing Ivermectin to augment chemotherapy’s efficacy in osteosarcoma
-
GASTRIC CANCER – (2021 Rabben et al) – Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer
-
LEUKEMIA – (2020, de Castro et al) – Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
-
ESOPHAGEAL SCC – (2020, Chen et al) – Ivermectin suppresses tumor growth and metastasis through degradation of PAK1 in esophageal squamous cell carcinoma
-
CHOLANGIOCARCINOMA – (2019 Intyuod et al) – Anti-parasitic drug ivermectin exhibits potent anticancer activity against gemcitabine-resistant cholangiocarcinoma in vitro
-
BREAST CANCER STEM CELLS – (2018 Dominguez-Gomez et al) – Ivermectin as an inhibitor of cancer stem-like cells
-
CML (CHRONIC MYELOID LEUKEMIA) – (2018 Wang et al) – Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
-
RENAL CELL CARCINOMA – (2017 Zhu et al) – Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
-
GLIOBLASTOMA – (2016 Liu et al) – Anthelmintic drug ivermectin inhibits angiogenesis, growth, and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
Dr. Makis asserts that Ivermectin holds significant promise in cancer treatment and elucidates the reasons behind the medical community’s reluctance to investigate its potential:
IVERMECTIN has demonstrated anti-cancer properties against approximately 20 cancer types, albeit primarily in preclinical settings. Clinical trials are unlikely to materialize due to Ivermectin’s low cost and off-patent status. Merck, once the patent holder for Ivermectin, has allied with Moderna to develop mRNA cancer vaccines, which are projected to cost around 400,000 GBP per treatment. Research on Ivermectin has been conducted on various cancers, including breast cancer, colon cancer, glioblastoma, glioma, and leukemia. However, studies on lymphoma, testicular cancer, and sarcomas are lacking. Ivermectin primarily acts on cancer by inhibiting pathways associated with cancer proliferation (Akt, Wnt, mTOR) and targeting cancer stem cells.
Dr. Makis is among the few medical professionals advocating for Ivermectin’s potential. The McCullough Foundation recently highlighted a positive new study:
The study, titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose Ivermectin in Cancer Treatment?” was published in the journal Acta Poloniae Pharmaceutica – Drug Research… This comprehensive systematic review indicates that ivermectin is safe for patients undergoing active chemotherapy. Its broad anticancer mechanisms observed in preclinical studies, coupled with anecdotal evidence of improvements in cancer symptoms, support its candidacy for repurposing. Well-structured, large-scale clinical trials should commence promptly to evaluate Ivermectin’s potential as an oncological therapy.
Moreover, combining Ivermectin with mebendazole has shown even greater promise in treating a diverse array of cancers.
Mebendazole, another anti-parasitic agent like Ivermectin, has been utilized for a century to tackle parasitic infections—affecting over 60 million Americans today, according to the CDC.
Safe, Effective, and Affordable!
If you’re feeling unwell, a parasite cleanse might be your path back to health. The optimal cleanse combines pure lab-tested Ivermectin + Mebendazole, compounded into a single capsule by The Wellness Company.
-
Ivermectin and Mebendazole synergize effectively in treating parasitic infections.
-
90 Oral Capsules, each containing 25mg Ivermectin + 250mg Mebendazole, a clinically effective dosage.
-
The Gold Standard of safety and efficacy; the only medication of its kind prescribed by a licensed doctor and compounded by a licensed pharmacy in all 50 states.
Trusted Medication from a Reputable Source in the USA
The medical experts at The Wellness Company—such as Dr. Peter McCullough and Dr. Kelly Victory—played crucial roles in disseminating accurate medical information during the COVID crisis. These professionals have consistently prioritized patient health and welfare over pharmaceutical profit motives.
Currently, The Wellness Company is the only entity globally to prescribe pure compounded Ivermectin + Mebendazole from a 50-state licensed pharmacy, offering a high-dose 90-day supply.
The Wellness Company’s Ivermectin + Mebendazole Parasite Cleanse is in high demand, having sold out three times, prompting the company to stockpile medication to ensure availability amid potential supply chain disruptions.
With the specter of tariffs limiting international trade, many individuals have resorted to dubious overseas medication sources or unlicensed pharmacies. The Wellness Company proudly stands as the only legitimate producer of this compounded formula in the U.S.
Visit The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse: Ivermectin + Mebendazole. Simply complete a brief intake questionnaire after your purchase to finalize your prescription request.
Here’s what customers are saying about The Wellness Company’s Ivermectin + Mebendazole:
Gastrointestinal issues resolved within 24 hours. By day three, the so-called “unexplained joint and muscle pain” diagnosed as part of Persian Gulf illness had lessened. By day four, the gastric reflux that kept me from enjoying coffee or fatty foods had almost completely disappeared… I could continue listing the improvements I suspect are due to the Parasite Cleanse, but these symptoms are directly attributable to the Ivermectin and Mebendazole. – Stephen
I’m grateful for a medication as potentially beneficial as ivermectin and mebendazole. Most importantly, I trust Dr. McCullough and The Wellness Company to provide a safe product made in the U.S. I appreciate their commitment to using proven products and the peace of mind that comes with knowing I’m using exactly what the labels indicate. – Jennifer W.
My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She began taking ivermectin/mebendazole two weeks ago. A PET scan last month revealed her lungs were filled with dime and pea-sized nodules. After a biopsy on April 14, the physician had to SEARCH for a sizable nodule to sample, and the one he found was only a few centimeters wide… Thank you to all the doctors here for providing us with HOPE and HEALING!!! – Helen
Click here to order Ivermectin and Mebendazole from The Wellness Company today.
Note: The information provided on this website is for informational purposes only and should not be taken as medical advice or a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.
